PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 CANCER IMMUNOL RES 杂志介绍 收藏
缩写名/全名
CANCER IMMUNOL RES
Cancer Immunology Research
ISSN号 2326-6066
研究方向 ONCOLOGY-IMMUNOLOGY
影响因子 2015:6.665, 2016:8.284, 2017:9.188, 2018:8.619, 2019:8.728,
出版国家 UNITED STATES
出版周期
年文章数 174
出版年份 0
是否OA No
审稿周期(仅供参考)
录用比例
投稿链接 https://cir.msubmit.net/cgi-bin/main.plex
投稿官网 http://cancerimmunolres.aacrjournals.org/
h-index 62
CiteScore
CiteScoreSJRSNIPCiteScore排名
8.584.9901.538
学科分区排名
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q18 / 191
大类:Immunology and Microbiology
小类:Immunology
Q110 / 198

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2326-6066%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
大类学科小类学科Top期刊综述期刊
医学 1区1区1区
IMMUNOLOGY
免疫学
4区3区1区
ONCOLOGY
肿瘤学
3区3区2区
中科院SCI期刊分区
( 2020年新版本)
大类学科小类学科Top期刊综述期刊
医学 4区2区3区
ONCOLOGY
肿瘤学
3区4区2区
IMMUNOLOGY
免疫学
4区3区2区
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3.

Author: Ding L#1, Chen X#1, Xu X1, Qian Y2, Liang G1, Yao F1, Yao Z1, Wu H1, Zhang J1, He Q3, Yang B3.
Journal: Cancer Immunol Res. 2019 Jan;7(1):136-149. doi: 10.1158/2326-6066.CIR-18-0071. Epub 2018 Nov 6.
    PubMed      DOI
2.Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells.

Author: Chen Y#1, Ma D#1, Wang X#1, Fang J1, Liu X1, Song J1, Li X1, Ren X1, Li Q1, Li Q1, Wen S1, Luo L2, Xia J1, Cui J3, Zeng G2, Chen L4, Cheng B5, Wang Z5.
Journal: Cancer Immunol Res. 2019 Jan;7(1):123-135. doi: 10.1158/2326-6066.CIR-18-0124. Epub 2018 Nov 6.
    PubMed      DOI
3.LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.

Author: Cao J1, Dong R1,2, Jiang L1, Gong Y1, Yuan M1, You J1, Meng W2, Chen Z3, Zhang N4, Weng Q1, Zhu H1, He Q1, Ying M5, Yang B5.
Journal: Cancer Immunol Res. 2019 Feb;7(2):292-305. doi: 10.1158/2326-6066.CIR-18-0145. Epub 2018 Nov 20.
    PubMed      DOI
4.Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages.

Author: Zha H1,2,3, Wang X1,2, Zhu Y1,2, Chen D1,2, Han X1,2, Yang F4, Gao J1,2, Hu C1,2, Shu C1,2, Feng Y1,2, Tan Y5, Zhang J4, Li Y6, Wan YY7, Guo B8, Zhu B9,2.
Journal: Cancer Immunol Res. 2019 Feb;7(2):193-207. doi: 10.1158/2326-6066.CIR-18-0272. Epub 2018 Dec 4.
    PubMed      DOI
5.LIN28/let-7/PD-L1 Pathway as a Target for Cancer Immunotherapy.

Author: Chen Y#1,2, Xie C#1, Zheng X1,3, Nie X1, Wang Z2, Liu H1, Zhao Y4,2.
Journal: Cancer Immunol Res. 2019 Mar;7(3):487-497. doi: 10.1158/2326-6066.CIR-18-0331. Epub 2019 Jan 16.
    PubMed      DOI
6.Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.

Author: Xu-Monette ZY#1, Xiao M#1, Au Q#2, Padmanabhan R#3, Xu B4, Hoe N3, Rodríguez-Perales S5, Torres-Ruiz R5,6, Manyam GC7, Visco C8, Miao Y1, Tan X1, Zhang H1, Tzankov A9, Wang J7, Dybkær K10, Tam W11, You H12, Bhagat G13, Hsi ED14, Ponzoni M15, Ferreri AJM15, Møller MB16, Piris MA17, van Krieken JH18, Winter JN19, Westin JR20, Pham LV1, Medeiros LJ1, Rassidakis GZ21, Li Y22, Freeman GJ23, Young KH24,25.
Journal: Cancer Immunol Res. 2019 Apr;7(4):644-657. doi: 10.1158/2326-6066.CIR-18-0439. Epub 2019 Feb 11.
    PubMed      DOI
7.Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer.

Author: Zhao S#1, Ren S#1, Jiang T#1, Zhu B2, Li X3, Zhao C3, Jia Y1, Shi J1, Zhang L1, Liu X1, Qiao M1, Chen X1, Su C1, Yu H4, Zhou C5, Zhang J6, Camidge DR7, Hirsch FR4,8.
Journal: Cancer Immunol Res. 2019 Apr;7(4):630-643. doi: 10.1158/2326-6066.CIR-17-0640. Epub 2019 Feb 12.
    PubMed      DOI
8.Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies.

Author: Ahn S1,2, Li J3,4, Sun C1,2, Gao K3,4, Hirabayashi K2, Li H2,5, Savoldo B1,2,6, Liu R7,3,4, Dotti G8,2.
Journal: Cancer Immunol Res. 2019 May;7(5):773-783. doi: 10.1158/2326-6066.CIR-18-0636. Epub 2019 Mar 6.
    PubMed      DOI
9.Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.

Author: Zeng D#1, Li M#1, Zhou R1, Zhang J1, Sun H1, Shi M1, Bin J2, Liao Y2, Rao J3, Liao W4.
Journal: Cancer Immunol Res. 2019 May;7(5):737-750. doi: 10.1158/2326-6066.CIR-18-0436. Epub 2019 Mar 6.
    PubMed      DOI
10.The Pseudogene Olfr29-ps1 Promotes the Suppressive Function and Differentiation of Monocytic MDSCs.

Author: Shang W1,2,3, Gao Y1,2,3, Tang Z1,2,3, Zhang Y1,2,3, Yang R4,2,3.
Journal: Cancer Immunol Res. 2019 May;7(5):813-827. doi: 10.1158/2326-6066.CIR-18-0443. Epub 2019 Mar 26.
    PubMed      DOI
同类著名期刊名称 h-index CiteScore
Journal of Allergy and Clinical Immunology-In Practice403.14
OncoImmunology584.51
OncoImmunology493.96
ALLERGOLOGY INTERNATIONAL452.66
Allergy Asthma & Immunology Research353.30
Immunity & Ageing383.86
Infectious Agents and Cancer302.38
Human Vaccines & Immunotherapeutics432.21
Allergy Asthma and Clinical Immunology262.64
Endocrine Metabolic & Immune Disorders-Drug Targets441.96
中科院JCR同大类学科的热搜期刊 浏览次数
MEDICINE299434
CANCER RESEARCH165669
Molecular Medicine Reports164428
International Journal of Nanomedicine164214
CANCER LETTERS159244
JOURNAL OF ETHNOPHARMACOLOGY141410
BIOMEDICINE & PHARMACOTHERAPY140235
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY135747
Theranostics135669
International Journal of Environmental Research and Public Health133383